Institutional investors purchased a net $2.0 million shares of RTIX during the quarter ended March 2013 and now own 83.34% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
PARADIGM CAPITAL MANAGEMENT, INC... Bought 1.3 Million shares of RTI Biologics Inc